FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Kudo, Masatoshi; Finn, Richard S.; Merle, Philippe et al.
Lenvatinib plus pembrolizumab versus lenvatinib alone as first-line therapy for advanced hepatocellular carcinoma: Longer-term efficacy and safety results from the phase 3 LEAP-002 study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 3_SUPPL. 2024 S. 482-482
Schroeter, Marco R.; Eschholz, Norman; Herzberg, Sebastian et al.
Leptin-Dependent and Leptin-Independent Paracrine Effects of Perivascular Adipose Tissue on Neointima Formation (vol 33, pg 980, 2013)ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Bd. 44. H. 7. 2024 S. e207-e207
Armandi, Angelo; Schuppan, Detlef; Schattenberg, Jorn M.
Letter: Breaking new ground-Understanding the role of ATI-free diet in managing MASLD-Authors' replyALIMENTARY PHARMACOLOGY & THERAPEUTICS. Bd. 60. H. 2. 2024 S. 304-305
Wang, Dong; Tediashvili, Grigol; Kim, Daniel et al.
Leukotriene B4: A potential mediator and biomarker for cardiac allograft vasculopathyJOURNAL OF HEART AND LUNG TRANSPLANTATION. Bd. 43. H. 8. 2024 S. 1336-1347
Kovlyagina, Irina; Wierczeiko, Anna; Todorov, Hristo et al.
Leveraging interindividual variability in threat conditioning of inbred mice to model trait anxietyPLOS BIOLOGY. Bd. 22. H. 5. 2024
Muschalla, B; Brähler, E
Life values in different age groups before and after global health crisis: A comparison of two German representative cohorts in 2018 and 2022J Clin Basic Psychosom. Bd. 2. H. 2. 2024 S. 1-7
Mekschrat, Liza; Strasser, Torsten; Ghassabei, Shiwa et al.
Light Exposure on Alertness after Wake-Up in Healthy Men: Comparing Dim, Bright, Red, and Blue LightNEUROPSYCHOBIOLOGY. Bd. 83. H. 5-6. 2024 S. 183-192
Luffy, Maximilian; Ganz, Anna-Lena; Wagner, Stefanie et al.
Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cellsFRONTIERS IN IMMUNOLOGY. Bd. 15. 2024
Bumma, Naresh; Richter, Joshua; Jagannath, Sundar et al.
Linvoseltamab for Treatment of Relapsed/Refractory Multiple MyelomaJOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 22. 2024
Bumma, Naresh; Richter, Joshua; Jagannath, Sundar et al.
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma (vol 42, pg 2702, 2024)JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 33. 2024 S. 4001-4001